Transition Metal Complexes with HIV/AIDS Inhibitory Properties

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 192

This Paper With 21 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CHRL-3-3_006

تاریخ نمایه سازی: 17 فروردین 1400

Abstract:

The management of HIV in the human body has been a major research area in the quest to either find the cure or the preventative scientific measure. The quest to manage the virus has been successful using some organic molecules which target one or more of the stages of the replication cycle of HIV rendering it inhibited to continue infecting other host cells. However, the approach is now moving to use of transition metal complexes to manage the HIV infection in the host cells and this review highlights the relevant contributions of such as HIV/AIDS inhibitors. There have been increasing number of reports on the trends for transition metal complexes with anticancer and antimicrobial activity hence this probed the need of such a review. Complexes of vanadium, manganese, iron, copper, cobalt, nickel, zinc, ruthenium, platinum and gold have been reported to be active against HIV-1 virus. The complexes discussed in this review showed anti-viral activity compared to the vehicle control.

Authors

Florence Nareetsile

University of Botswana

James Matshwele

Botho Univeristy

Scotch Ndlovu

Baisago University

Mustapha Ngaski

University of Botswana

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • [1] K. Benjamin Garbutcheon-Singh, M. P. Grant, B. W. Harper, ...
  • [2] C. M. Che, F. M. Siu, Metal complexes in ...
  • [3] R. W. Y. Sun, D. L. Ma, E. L. ...
  • HIV agents. Dalt Trans. 43 (2007) 4884-4892. ...
  • [4] T. W. Hambley, Developing new metal-based therapeutics: Challenges and ...
  • [5] B. Lu, D. Ennis, R. Lai, et al. Enhanced ...
  • Insulin-resistant Adipocytes to Vanadate is Associated with Oxidative Stress and ...
  • [6] S. Trudel, M. R. Paquet, S. Grinstein, Mechanism of ...
  • [7] H. Sakurai, M. Nakai, T. Miki, K. Tsuchiya, J. ...
  • [8] K. H. Thompson, C. Orvig, Coordination chemistry of vanadium ...
  • [9] O. J. D’Cruz, Y. Dong, F. M. Uckun, Potent ...
  • [10] A. Bacchi, M. Carcelli, C. Compari, et al. HIV-1 ...
  • [11] J. Didierjean, C. Isel, F. Querre, et al. Inhibition ...
  • [12] B. S. Van Asbeck, N. A. Georgiou, T. Van ...
  • [13] C. Sappey, J. R. Boelaert, S. Legrand-Poels, C. Forceille, ...
  • [14] E. C. Moore, M. S. Zedeck, K. C. Agrawal, ...
  • [15] S. M. Hecht, RNA Degradation by Bleomycin, a Naturally ...
  • [16] N. Georgiou, T. van der Bruggen, M. Oudshoorn, H. ...
  • [17] A. R. Karlström, R. L. Levine, Copper inhibits the ...
  • [18] N. V. Loginova, T. V. Koval’chuk, G. I. Polozov, ...
  • [19] S. A. Galal, A. S. Abd El-All, K. H. ...
  • [20] S. García-Gallego, M. J. Serramía, E. Arnaiz, et al. ...
  • Transition-metal complexes based on a sulfonate-containing N-donor ligand and their ...
  • [21] F. Lebon, N. Boggetto, M. Ledecq, et al. Metal-organic ...
  • [22] G. Pelosi, F. Bisceglie, F. Bignami, et al. Antiretroviral ...
  • [23] Q. Wang, Y. T. Wang, S. P. Pu, Y. ...
  • [24] E. De Clercq, Current lead natural products for the ...
  • infection. Med Res Rev., 20 (2000) 323-349. ...
  • [25] B. Q. Li, T. Fu, Y. Dongyan, J. A. ...
  • [26] I. Neves, A. L. Bertho, V. G. Veloso, D. ...
  • [27] Y. Haraguchi, H. Sakurai, S. Hussain, B. M. Anner, ...
  • [28] A. Ross, J. Choi, T. M. Hunter, et al. ...
  • [29] E. Wong, R. W. Y. Sun, N. P. Y. ...
  • [30] J. S. Oxford, M. A. Zuckerman, E. Race, R. ...
  • [31] C. J. Elias, L. L. Heise, Challenges for the ...
  • [32] A. N. Vzorov, D. Bhattacharyya, L. G. Marzilli, R. ...
  • [33] N. A. Al-Masoudi, B. A. Saleh, N. A. Karim, ...
  • [34] P. N. Fonteh, F. K. Keter, D. Meyer, New ...
  • [35] H. Beraldo, D. Gambino, The Wide Pharmacological Versatility of ...
  • [36] W. Hernándeza, J. Paz, A. Vaisberg, E. Spodine, R. ...
  • [37] V. Mishra, S. N. Pandeya, C. Pannecouque, M. Witvrouw, ...
  • De Clercq, Anti-HIV activity of thiosemicarbazone and semicarbazone derivatives of ...
  • [38] S. P. Pricker, Medical uses of gold compounds: Past, ...
  • [39] P. N. Fonteh, F. K. Keter, D. Meyer, I. ...
  • [40] Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)methane)gold(III) ...
  • chloride: An HIV-1 reverse transcriptase and protease inhibitor. J Inorg ...
  • [41] M. Mphahlele, M. Papathanasopoulos, M. A. Cinellu, et al. ...
  • نمایش کامل مراجع